Absci Management
Management criteria checks 2/4
Absci's CEO is Sean McClain, appointed in Aug 2011, has a tenure of 13.33 years. total yearly compensation is $3.10M, comprised of 20% salary and 80% bonuses, including company stock and options. directly owns 7.56% of the company’s shares, worth $26.14M. The average tenure of the management team and the board of directors is 2 years and 1.8 years respectively.
Key information
Sean McClain
Chief executive officer
US$3.1m
Total compensation
CEO salary percentage | 20.0% |
CEO tenure | 13.3yrs |
CEO ownership | 7.6% |
Management average tenure | 2yrs |
Board average tenure | 1.8yrs |
Recent management updates
Recent updates
Absci Corporation: Struggling To Live Up To Its AI Promise
Nov 20Is Absci (NASDAQ:ABSI) A Risky Investment?
Nov 13Absci: Embryonic Pipeline Looks Expensive Relative To Peers
Oct 29Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile
Oct 03Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships
Jul 28Is Absci (NASDAQ:ABSI) A Risky Investment?
Jun 17Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula
May 16Absci: Differentiated Antibody Discovery Play
Feb 27Absci GAAP EPS of -$0.32 misses by $0.01, revenue of $1M misses by $0.68M
Aug 11Absci teams up to help develop antibody drugs for cancer
Jul 07Merck And Absci: AI-Driven Drug Development Deal Has Promise, But May Take Years To Pay Out
Jan 10IPO Day With Absci CEO Sean McClain - The Google Of Synthetic Biology (Video)
Jul 22CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$98m |
Jun 30 2024 | n/a | n/a | -US$92m |
Mar 31 2024 | n/a | n/a | -US$109m |
Dec 31 2023 | US$3m | US$620k | -US$111m |
Sep 30 2023 | n/a | n/a | -US$106m |
Jun 30 2023 | n/a | n/a | -US$112m |
Mar 31 2023 | n/a | n/a | -US$99m |
Dec 31 2022 | US$4m | US$600k | -US$105m |
Sep 30 2022 | n/a | n/a | -US$111m |
Jun 30 2022 | n/a | n/a | -US$107m |
Mar 31 2022 | n/a | n/a | -US$121m |
Dec 31 2021 | US$4m | US$505k | -US$103m |
Sep 30 2021 | n/a | n/a | -US$84m |
Jun 30 2021 | n/a | n/a | -US$73m |
Mar 31 2021 | n/a | n/a | -US$48m |
Dec 31 2020 | US$1m | US$260k | -US$49m |
Compensation vs Market: Sean's total compensation ($USD3.10M) is above average for companies of similar size in the US market ($USD2.15M).
Compensation vs Earnings: Sean's compensation has been consistent with company performance over the past year.
CEO
Sean McClain (34 yo)
13.3yrs
Tenure
US$3,097,371
Compensation
Mr. Sean Mcclain is the Founder of Absci Corporation (formerly known as AbSci, LLC) and serves as its Chief Executive Officer since August 2011 and Director since its formation in October 2020. Mr. Mcclain...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 13.3yrs | US$3.10m | 7.56% $ 26.1m | |
Chief Business Officer & CFO | 1.3yrs | US$2.20m | 0.084% $ 291.3k | |
Chief Innovation Officer & Member of Scientific Advisory Board | 2.2yrs | US$2.15m | 0.048% $ 166.3k | |
Senior VP & Chief Accounting Officer | 2.4yrs | no data | 0.027% $ 93.6k | |
VP of Finance & Head of Investor Relations | 1.8yrs | no data | no data | |
Chief Legal Officer | less than a year | no data | no data | |
Chief People Officer | 1.9yrs | no data | no data | |
Chief of Staff | 2.8yrs | no data | no data | |
Senior Vice President of Synthetic Biology R&D | 2.9yrs | no data | no data | |
Chief of Staff | 2.9yrs | no data | no data | |
Senior Vice President of Portfolio & Growth Strategy | 1.8yrs | no data | no data | |
Senior Vice President of Drug Creation | 1.8yrs | no data | no data |
2.0yrs
Average Tenure
50yo
Average Age
Experienced Management: ABSI's management team is considered experienced (2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 4.2yrs | US$3.10m | 7.56% $ 26.1m | |
Chief Innovation Officer & Member of Scientific Advisory Board | less than a year | US$2.15m | 0.048% $ 166.3k | |
Lead Independent Director | 4.3yrs | US$169.46k | 0.013% $ 45.2k | |
Independent Director | 1.5yrs | US$171.92k | 0% $ 0 | |
Independent Director | 2.1yrs | US$96.37k | 0% $ 0 | |
Member of Scientific Advisory Board | less than a year | no data | no data | |
Independent Director & Member of Scientific Advisory Board | less than a year | no data | 0% $ 0 | |
Independent Director | 2.9yrs | US$101.59k | 0% $ 0 | |
Independent Director | 4.2yrs | US$108.87k | 0% $ 0 | |
Member of Scientific Advisory Board | 1.8yrs | no data | no data | |
Member of Scientific Advisory Board | 1.8yrs | no data | no data |
1.8yrs
Average Tenure
57yo
Average Age
Experienced Board: ABSI's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 01:56 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Absci Corporation is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Ryskin | BofA Global Research |
Tiago Fauth | Credit Suisse |
Vamil Divan | Guggenheim Securities, LLC |